Abstracts

MODELING THE IMPACT OF HIV AND TB INTERVENTIONS ON SOUTH AFRICAN TB TRENDS: 1990-2019

The South African tuberculosis (TB) epidemic is largely driven by HIV. Interventions including directly observed therapy (DOTS), antiretroviral therapy (ART), isoniazid preventative therapy (IPT), increased TB screening, and Xpert MTB/RIF have been implemented to reduce TB incidence and mortality. This study aimed to estimate the impact of HIV and interventions on the South African TB…

CLINICAL AND LABORATORY PREDICTORS OF TUBERCULOSIS RECURRENCE

Despite successful completion of therapy for drug-susceptible pulmonary tuberculosis (PTB), a subset of individuals experience an unfavorable treatment outcome of tuberculosis (TB) recurrence. India accounts for 26% of the global burden of TB and few data on predictors of TB recurrence exist, especially with a focus on India. A TB recurrence prediction model could enable…

PATIENT-LEVEL POOLED ANALYSIS OF STUDY 31/A5349: A STRATIFIED MEDICINE APPROACH

Study 31/A5349 (NCT02410772) was a phase 3 randomized controlled trial assessing 4-month regimens of once-daily isoniazid, rifapentine, and pyrazinamide plus moxifloxacin (HPZM) or ethambutol (HPZE) compared to the 6-month HZE + rifampicin standard treatment for drug-sensitive tuberculosis (TB). While HPZM arm successfully demonstrated noninferiority, HPZE arm did not. Nonetheless, 82% of participants receiving HPZE were…

CRISPR-DETECTED CELL-FREE DNA FOR PEDIATRIC TB DIAGNOSIS AND TREATMENT RESPONSE

Children with HIV (CHIV) are at high risk for tuberculosis (TB)-related morbidity and mortality but often missed by sputum-based assays. We developed a CRISPR-based TB assay (CRISPR-TB) that detects an M. tuberculosis (Mtb)-specific multicopy insertion element (IS6110) in cell-free DNA (cfDNA) isolated from 200µl serum samples. We evaluated CRISPR-TB performance using cryopreserved serum from hospitalized…